希毅醫(yī)學(xué)是一家以全球臨床試驗(yàn)為業(yè)務(wù)核心的CRO公司，為中國(guó)生物醫(yī)藥與醫(yī)療器械企業(yè)提供定制化出海解決方案，服務(wù)內(nèi)容包括出海策略咨詢、海外臨床試驗(yàn)申請(qǐng)與實(shí)施、海外產(chǎn)品注冊(cè)及商業(yè)化布局。自創(chuàng)立起，希毅醫(yī)學(xué)已成功幫助超過(guò)50個(gè)醫(yī)藥和器械項(xiàng)目在海外順利落地，為客戶累計(jì)帶來(lái)超過(guò)160億人民幣的利潤(rùn)。目前，希毅醫(yī)學(xué)自有海外臨床團(tuán)隊(duì)超100人，合作專家超2000位，簽約海外合作醫(yī)院超100個(gè)，覆蓋歐盟、北美、澳新、東南亞、日韓、中東、非洲等地區(qū)。
MDCE?is?a?CRO?with?global?clinical?trials?as?its?core?business.?MDCE?provides?customized?solutions?for?Chinese?biopharmaceutical?and?medical?device?companies?to?go?global.?MDCE’s?services?include?consulting?and?strategy?development?of?overseas?clinical?trials,?overseas?clinical?trial?management?and?operations,?overseas?product?registration?and?commercialization.?Since?its?establishment,?MDCE?has?successfully?helped?over?50?biopharmaceutical?and?medical?device?projects?land?overseas,?generating?accumulated?overseas?profits?exceeding?16?billion?RMB?for?its?clients.?Currently,?MDCE?has?its?own?overseas?clinical?trial?team?of?over?100?members,?collaborating?with?over?2,000?experts?and?partnering?with?more?than?100?well-known?overseas?hospitals?across?the?EU,?North?America,?Australia,?New?Zealand,?Southeast?Asia,?Japan,?South?Korea,?the?Middle?East,?Africa,?and?other?regions.